Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis-Reference-Cited by-同舟云学术

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

Published:2019-08-28 Issue:11 Volume:33 Page:2710-2719
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Knop Stefan, ,Engelhardt Monika,Liebisch Peter,Meisner Christoph,Holler Ernst,Metzner Bernd,Peest Dietrich,Kaufmann Martin,Bunjes Donald,Straka Christian,Fischer Thomas,Sezer Orhan,Hentrich Marcus,Ostermann Helmut,Bassermann Florian,Hess Georg,Hertenstein Bernd,Freund Mathias,Kropff Martin,Schmidt Christian A.,Wolf Hans-Heinrich,Jung Wolfram,Frickhofen Norbert,Mielke Stephan,Bargou Ralf C.,Maschmeyer Georg^ORCID,Svaldi Mirija,Langer Christian H.,Gramatzki Martin,Hebart Holger,Kanz Lothar,Einsele Hermann

Funder

The trial was sponsored by Würzburg University, Würzburg, Germany.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0537-2.pdf

Reference28 articles.

1. Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015;385:2197–208.

2. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335:91–97.

3. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003;349:2495–502.